Chemokines signal the future in the treatment of SARS-CoV-2 infection
In a recent report1, researchers have described an ELISA (enzyme-linked immunosorbent assay) approach for the identification and quantification of antibodies that attach to a functional N-terminal loop area in human chemokines using plasma from heterogeneous cohort previously infected with SARS-CoV-2.
